AFWM
VERV

Abich Financial Wealth Management’s Verve Therapeutics VERV Stock Holding History

Abich Financial Wealth Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.75K Buy
1,189
+905
+319% +$5.26K 0.01% 247
2024
Q2 		$1.39K Buy
284
+270
+1,929% +$1.7K ﹤0.01% 545
2024
Q1 		$186 Buy
+14
New +$186 ﹤0.01% 489

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Abich Financial Wealth Management's VERV Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Verve Therapeutics (VERV) stake by 319% in Q3 2024, buying an estimated $5.26K and bringing the position to 1,189 shares worth $5.75K. The position accounts for 0.01% of the portfolio, ranked #247.

Abich Financial Wealth Management first reported a position in VERV in Q1 2024 and has held it in 3 quarters since. 174 funds tracked by Wall St. Rank hold VERV as of Q3 2024.

  • Abich Financial Wealth Management held 1,189 shares of Verve Therapeutics worth $5.75K as of Q3 2024.
  • Abich Financial Wealth Management bought 905 Verve Therapeutics shares in Q3 2024, an estimated $5.26K.
  • Verve Therapeutics made up 0.01% of Abich Financial Wealth Management's portfolio in Q3 2024, its #247 holding.
  • Abich Financial Wealth Management first reported a position in Verve Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 174 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.